When physicians speak to an overweight child they should inquire carefully about a history of physical, sexual or emotional ...

The number of people prescribed GLP-1 drugs for weight management has skyrocketed over the past five years, according to new ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

Using Sernova Biotherapeutics' investigational Cell Pouch Bio-hybrid Organ, transplanted human donor islet cells helped ...

with eight incorporating Phenomix's machine learning-based algorithms. Together, the research highlights the growing role of precision medicine in advancing obesity care and drug development.

Medical science and attitudes toward obesity have changed significantly since the first set of guidelines were released in April 2007. While the original recommendations were focused on weight ...

The guidelines outlined in this study provide evidence for the benefits and potential adverse effects associated with various obesity management interventions, which facilitates informed decision ...

Obesity Canada’s first update to the pediatric obesity management guideline in almost 20 years was published in the Canadian Medical Association Journal this week.

The guidelines recommend GLP-1 medications ... “With only two surgical centres, a patchwork of multidisciplinary obesity management clinics, and widespread lack of equitable and affordable ...

Some, like Ozempic and Mounjaro, are approved to treat Type 2 diabetes in Canada, while Wegovy is approved for obesity. The guidelines also say some children struggling with weight management ...